The Oklahoma attorney general’s office said it will attempt to return a $2 million stockpile worth of hydroxychloroquine, the anti-malarial drug once described by former President Donald Trump as a potential treatment for COVID-19, a spokesman said Wednesday.
The stockpile of 1.2 million hydroxychloroquine pills was sent to Oklahoma in April from a supplier in California, FFF Enterprises, a private pharmaceutical company, the Frontier reported.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
